Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

OPULINK CORPORATION — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Termination

OPULINK CORPORATION

4th Quarter (Oct 1 - Dec 31) · 2008Posted Jan 16, 2009Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: OPULINK CORPORATION
Description: Opulink provides Clinical Site Management for clinical trials.
Location: Maryland · United States of America

Registrant

Firm: GAGE, LLC
Description: Lobbying and Business Consulting Services
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Budget/Appropriations
Appropriations for Native American health research
LobbyistsRYAN THOMAS · mr WILL HUNT
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.